Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8012936 Tau fragments for immunotherapy

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
March 29, 2007
Date of Patent
September 6, 2011
Patent Application Number
11693375
Patent Citations Received
‌
US Patent 12122844 Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies
0
‌
US Patent 11958898 Antibody-based molecules specific for the truncated ASP421 epitope of Tau and their uses in the diagnosis and treatment of tauopathy
0
‌
US Patent 11958896 Antibodies recognizing tau
0
‌
US Patent 12024568 Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies
0
‌
US Patent 11673944 Treatment of tauopathies
0
‌
US Patent 11787854 Immunological targeting of pathological tau proteins
‌
US Patent 11839654 Combination therapy
0
‌
US Patent 11851425 Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines
0
‌
US Patent 11926659 Antibodies recognizing tau
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8012936
Patent Primary Examiner
‌
Olga N. Chernyshev

Find more entities like US Patent 8012936 Tau fragments for immunotherapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.